RxDoctor Payments Data

Manica Isiguzo

Pulmonary Disease · Beachwood, OHNPI 1932158078

Payments from drug & device makers

$58,301in general payments, 2019–2025

Across 582 payments — averaging $100.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$28K
  • Genentech USA, Inc.$15K
  • Actelion Pharmaceuticals US, Inc.$5K
  • Bayer$3K
  • GSK$2K
  • AstraZeneca$1K
  • plus $4K from 26 others

What the payments were for

  • Consulting fees$7,74513%
  • Speaking & faculty fees$35,58061%
  • Travel & lodging$4,2367%
  • Food & beverage$10,67718%
  • Education$650%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,301 in reported general payments places this provider in the 85th percentile of 571 pulmonary disease providers in Ohio.

See all pulmonary disease providers in Ohio

Other pulmonary disease in Beachwood

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →